U.S. Residential REITs Stock News

Wondering if Sun Communities at around US$129.99 is offering fair value or a potential mispricing opportunity? This article walks you through what the numbers actually suggest. The stock has returned 1.7% over the last 7 days, 6.4% year to date and 10.9% over the last year, while the 30 day return sits at a slight 0.2% decline and the 3 and 5 year returns are 4.4% and 0.9% declines respectively. Recent coverage of Sun Communities has focused on its role as a large US real estate owner and...

Some Saia, Inc. ( NASDAQ:SAIA ) shareholders may be a little concerned to see that the Executive VP & Chief Customer...

The analysts covering Forrester Research, Inc. ( NASDAQ:FORR ) delivered a dose of negativity to shareholders today, by...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Envoy Medical, Inc. ( NASDAQ:COCH ) shareholders (or potential shareholders) will be happy to see that insider Glen...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

United Fire Group, Inc. ( NASDAQ:UFCS ) stock is about to trade ex-dividend in 4 days. The ex-dividend date occurs one...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Some Loews Corporation ( NYSE:L ) shareholders may be a little concerned to see that insider Andrew Tisch recently sold...

What Playtika’s New Credit Facility Means for Investors Playtika Holding (PLTK) has amended and refinanced its existing revolving credit facility, keeping the size at $550 million while extending the maturity to March 2027 and maintaining similar terms. This debt move arrives alongside reaffirmed full year revenue and adjusted EBITDA guidance and ongoing cost cuts, including a planned 15% workforce reduction as the company increases its use of AI automation. See our latest analysis for...

If you are wondering whether DigitalBridge Group is still attractively priced after its recent run, looking closely at its valuation metrics can help you decide what the current share price really offers. The stock last closed at US$15.41, with returns of 0.0% over 7 days, 0.4% over 30 days, 0.2% year to date, 43.9% over 1 year, 13.5% over 3 years, and a 36.3% decline over 5 years. Taken together, these figures give a mixed picture of how the market has treated the shares over different...

BrightSpring Health Services (NasdaqGS:BTSG) has been added to several S&P indices, including the S&P SmallCap 600 and S&P Composite 1500. The index changes highlight growing attention from institutional investors toward the company. Recent contract wins for high margin specialty drugs serving complex conditions are supporting business momentum. BrightSpring operates in healthcare services and specialty pharmaceuticals, areas that sit at the intersection of aging demographics, chronic...

If you are wondering whether AAR's current share price lines up with its underlying worth, this article will walk through what the numbers are actually saying about value. AAR's stock last closed at US$114.63, with returns of 0.9% over the past 7 days, 9.1% over 30 days, 35.7% year to date, 78.3% over 1 year, 112.5% over 3 years, and 168.0% over 5 years, which may influence how much upside or downside you feel is left. Recent news coverage around AAR has largely focused on its role in the...

NCR Atleos recently expanded access for UnionPay cardholders, allowing them to withdraw cash at up to 13,000 Cashzone ATMs across the UK, many located in high-traffic and tourist areas. This collaboration underscores NCR Atleos’ role in cross-border cash access and tourism-related payments, reinforcing its position in self-directed banking infrastructure. We’ll now explore how this wider UnionPay access across Cashzone ATMs could influence NCR Atleos’ investment narrative and long-term cash...

FirstEnergy FY 2025 Earnings Snapshot FirstEnergy (FE) just posted its latest FY 2025 numbers with Q3 revenue of US$4.1 billion and basic EPS of US$0.76, setting a clear marker for how the year is shaping up. The company has seen revenue move from US$3.0 billion in Q4 2024 to US$3.4 billion in Q2 2025 and US$4.1 billion in Q3 2025, while quarterly EPS ranged from US$0.45 to US$0.76 over the same stretch, and trailing twelve month EPS sits at US$2.31 on revenue of US$14.3 billion. With net...

In February 2026, Mirion Technologies reported full-year 2025 revenue of US$925.4 million and net income of US$28.8 million, issued guidance for approximately low-twenties percentage revenue growth in 2026, announced record annual orders above US$1 billion, and reshaped its leadership team with new nuclear, nuclear medicine, and AI-focused roles. By elevating nuclear power and nuclear medicine leadership and appointing a Chief Artificial Intelligence & Digital Officer, Mirion is explicitly...

In its fourth-quarter 2025 investor letter, Gator Capital Management disclosed that it had purchased a position in TFS Financial Corporation in December, citing the bank’s mutual holding company structure and the benefit of lower short-term interest rates. Gator Capital Management highlighted that this structure, combined with what it views as an underappreciated earnings recovery potential, could create an attractive, asymmetric risk/reward profile for public shareholders. With these...

Genius Sports (NYSE:GENI) announced the acquisition of Legend, triggering debate about the target’s quality and the terms of the deal. Critics have questioned the purchase price and the effect on Genius Sports’ leverage profile. The CEO responded with a detailed letter, describing Legend as a technology focused business and outlining expected revenue synergies from the combination. Genius Sports operates as a sports data and technology provider, supplying leagues, sportsbooks, and media...

ImmunityBio's lead oncology drug Anktiva has received conditional marketing authorization from the European Commission for bladder cancer, opening commercial access across 33 countries. The company is also securing accelerated approvals and advancing regulatory expansion in Saudi Arabia, adding to its international footprint. These regulatory decisions expand ImmunityBio's commercial reach in bladder cancer treatment across Europe and the Middle East. For investors tracking ImmunityBio...

Perion Network (PERI) just posted its FY 2025 third quarter numbers, reporting revenue of US$110.5 million and a loss per share of US$0.10 based on basic EPS, as net income excluding extra items came in at a US$4.1 million loss. The company’s quarterly revenue moved from US$108.7 million in Q2 2024 to US$102.2 million in Q3 2024 and then to US$110.5 million in Q3 2025. Over the same periods, basic EPS shifted from a loss of US$0.13 in Q2 2024 to EPS of US$0.05 in Q3 2024 and then a loss of...

Tactile Systems Technology (TCMD) has wrapped up FY 2025 with fourth quarter revenue of US$103.6 million and basic EPS of US$0.47, alongside trailing 12 month revenue of US$329.5 million and EPS of US$0.83 that frame the full year picture. The company has seen quarterly revenue move from US$61.3 million in Q1 2025 to US$103.6 million in Q4 2025, while basic EPS shifted from a loss of US$0.13 in Q1 to a profit of US$0.47 in Q4, setting up a results season where investors are likely to focus on...

JELD-WEN Holding (JELD) has just posted a tough FY 2025 finish, with fourth quarter revenue of US$802 million and a basic EPS loss of US$0.47, alongside trailing 12 month revenue of about US$3.2 billion and a full year basic EPS loss of US$7.27. The company has seen quarterly revenue move from US$895.7 million in Q4 2024 to US$802 million in Q4 2025, while basic EPS shifted from a loss of US$0.81 to a loss of US$0.47 over the same period. This leaves investors to consider whether pressure on...

If you are wondering whether Freeport-McMoRan at around US$62.55 is still offering value or has already priced in the story, you are in the right place for a closer look at what you are really paying for. The stock has moved around recently, with a 1 year return of 64.4%, 3 year return of 56.0%, 5 year return of 76.8%, a year to date return of 20.5%, a 30 day return of 6.5%, and a 7 day return that reflects a 4.4% decline. Recent headlines around Freeport-McMoRan have focused on factors such...

Global‑E Online (GLBE) has just posted its FY 2025 third quarter numbers, with revenue of US$220.8 million and basic EPS of US$0.08 on net income of US$13.2 million. This gives investors fresh data on how the cross border e commerce platform is converting top line scale into bottom line results. The company has seen quarterly revenue move from US$168.0 million in Q2 2024 to US$175.9 million in Q3 2024, then to US$189.9 million in Q1 2025, US$214.9 million in Q2 2025 and US$220.8 million in...